-
Vaccines, Blood & Biologics
-
Resources for You
-
-
Twinrix
Proper Name: Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine
Tradename: Twinrix
Manufacturer: GlaxoSmithKline Biologicals, License #1617
Indication:
- Active immunization of persons 18 years of age or older against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus
-
Product Information
-
-
Supporting Documents
- September 16, 2009 Approval Letter - Twinrix
Changes to the package insert regarding the possibility of cracked vials or syringes. - March 28, 2007 Approval Letter - Twinrix
Active immunization of persons 18 years of age or older against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus. - May 11, 2001 Approval Letter - Twinrix
For an accelerated dosing schedule of 0, 7, 21-30 days and a month 12 booster dose.
-
-
-

